[go: up one dir, main page]

AU4626301A - Tumor cells transformation process - Google Patents

Tumor cells transformation process

Info

Publication number
AU4626301A
AU4626301A AU46263/01A AU4626301A AU4626301A AU 4626301 A AU4626301 A AU 4626301A AU 46263/01 A AU46263/01 A AU 46263/01A AU 4626301 A AU4626301 A AU 4626301A AU 4626301 A AU4626301 A AU 4626301A
Authority
AU
Australia
Prior art keywords
tumor cells
transformation process
cells transformation
tumor
transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46263/01A
Other languages
English (en)
Inventor
Fernando Thome Kreutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FK BIOTECNOLOGIA S/A
Original Assignee
FK BIOTECNOLOGIA S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FK BIOTECNOLOGIA S A filed Critical FK BIOTECNOLOGIA S A
Publication of AU4626301A publication Critical patent/AU4626301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU46263/01A 2000-04-10 2001-04-09 Tumor cells transformation process Abandoned AU4626301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR0001029-4A BR0001029A (pt) 2000-04-10 2000-04-10 Processo de transformação de células tumorais
BR0001029 2000-04-10
PCT/BR2001/000045 WO2001077301A1 (en) 2000-04-10 2001-04-09 Tumor cells transformation process

Publications (1)

Publication Number Publication Date
AU4626301A true AU4626301A (en) 2001-10-23

Family

ID=3943798

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46263/01A Abandoned AU4626301A (en) 2000-04-10 2001-04-09 Tumor cells transformation process

Country Status (3)

Country Link
AU (1) AU4626301A (pt)
BR (1) BR0001029A (pt)
WO (1) WO2001077301A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9320785B2 (en) 2012-01-20 2016-04-26 Fernando Thome Kreutz Autologous cancer cell vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1119459A (zh) * 1993-03-19 1996-03-27 柏伦格-英格尔海姆国际股份公司 肿瘤疫苗的制备方法
CA2176257A1 (en) * 1993-11-10 1995-05-18 George Blanck Reestablishment of ifn-.gamma. inducibility or constitutive expression of mhc class ii in tumor cells

Also Published As

Publication number Publication date
WO2001077301A1 (en) 2001-10-18
BR0001029A (pt) 2001-11-20

Similar Documents

Publication Publication Date Title
AU2001280815A1 (en) Intellectual property investment process
AU2001227947A1 (en) Polycarbonate preparation process
AUPR143100A0 (en) Plant transformation
AU2000252139A1 (en) Hybrid antenna array
AU1538901A (en) Polymersation process
AU4981600A (en) Snowmaking process
AU1335201A (en) Hydrodesulfurization process
AU2002243235A1 (en) Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
AU2002218440A1 (en) New process
AU1571801A (en) Improved fermentation process
AU6006800A (en) Treating cells
AU2001267769A1 (en) Process
AUPR095200A0 (en) Cell production
AU4626301A (en) Tumor cells transformation process
AUPQ319799A0 (en) Chemical methods
AU2001264117A1 (en) Chemical process
AU2001271913A1 (en) Process guru
AUPP888299A0 (en) Improved eduction process
AU5550700A (en) Novel process
AU6169100A (en) Novel process
AU6386500A (en) Selection for more efficient transformation host cells
AUPR144100A0 (en) Process for can manufacture
AU7418600A (en) Fermentation process
AU2002217933A1 (en) Fission-voltaic reactor
AU2002244339A1 (en) Reactor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase